4
Changes in Ownership
Gossamer Bio, Inc. Filed Acc 0001728117-23-000057
Options or other derivatives
- Chief Medical Officer acquired 248,618 shares (grant or award)
- Chief Medical Officer returned 372,925 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Aranda Richard · Chief Medical Officer
Table II: Derivative
12 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-05 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −45,000 | 0 | D |
| 2023-05-05 | Returned to the company : show line 2 in the form Stock Option (Right to Buy) | −13,750 | 0 | D |
| 2023-05-05 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −34,175 | 0 | D |
| 2023-05-05 | Returned to the company : show line 4 in the form Stock Option (Right to Buy) | −60,000 | 0 | D |
| 2023-05-05 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −30,000 | 0 | D |
| 2023-05-05 | Returned to the company : show line 6 in the form Stock Option (Right to Buy) | −190,000 | 0 | D |
| 2023-05-05 | Grant or award : show line 7 in the form Stock Option (Right to Buy) | +30,000 | 30,000 | D |
| 2023-05-05 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +9,167 | 9,167 | D |
Loading xslF345X04/wf-form4_168366370450924.xml…